MRI Safety Promus PREMIER™ Everolimus-Eluting Platinum Chromium ...
[Pages:1]MRI Safety
Promus PREMIERTM Everolimus-Eluting Platinum Chromium Coronary Stent System
Below is an excerpt of Section 6.11 from the Directions for Use detailing the safety of performing MRI following the placement of a Promus PREMIER Stent.
Section 6.11 Magnetic Resonance Imaging (MRI) Safety Information
Non-clinical testing has demonstrated that the Promus PREMIER Stent is MR Conditional for single and overlapped conditions up to 74mm. A patient with this device can be safely scanned in an MR system meeting the following conditions:
Static magnetic field of 3.0 and 1.5 Tesla only Maximum spatial gradient magnetic field of 2200 gauss/cm (22 T/m) Maximum MR system reported, whole body averaged specific absorption rate (SAR) of >
Promus PREMIER is an unregistered or registered trademark of Boston Scientific or its affiliates. All other trademarks
are property of their respective owners. ? 2013 Boston Scientific Corporation or its affiliates. All rights reserved.
.
IC-185412-AA SEP2013 Page 1 of 1
................
................
In order to avoid copyright disputes, this page is only a partial summary.
To fulfill the demand for quickly locating and searching documents.
It is intelligent file search solution for home and business.
Related download
- 5945 review article magnetic resonance imaging of patients with airway
- guidelines for the management of patients with coronary artery ismrm
- radiology recent news department of radiology
- mri safety promus premier everolimus eluting platinum chromium
- intravascular palmaz schatz stent heart
- summary of safety and effectiveness data 1 general information
- coronary arterial stents safety and artifacts during
- table of contents boston scientific
- potential adverse events 2 clinical studies 2 6 innova vascular 3 6 us
- facilitated advancement of the palmaz schatz stent delivery system with